Airsupra is also the first ICS-containing product to win U.S. approval as a reliever treatment, rather than as a controller, for asthma. The inhalation aerosol is intended to treat or prevent bronchoconstriction and reduce the risk of asthma attacks in adult asthma patients, according to the FDA.
The product is made up of albuterol and budesonide, and the former is a popular asthma drug that is currently in shortage with “no presentations available,” according to the American Society of Health-System Pharmacist’s drug shortage website.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
